- S&P/TSX16,089.33-0.96%
- S&P 5002,800.71-1.90%
- DOW25,502.32-1.77%
- CAD/USD0.7458-0.0000%
- CRUDE OIL58.97-1.68%
- BTC-CAD5,347.40+0.30%
- GOLD FUTURES1,313.40+0.47%
- RUSSELL 20001,505.92-3.62%
- 10-Yr Bond2.4550-3.23%
- NASDAQ7,642.67-2.50%
- VOLATILITY16.48+20.91%
- FTSE7,207.59-2.01%
- NIKKEI 22521,627.34+0.09%
- CAD/EUR0.65950.00%
Aging Baby Boomers
1.39k followers • 12 symbols Watchlist by Yahoo Finance
This basket consists of stocks that benefit from the needs of aging baby boomers.
12 Symbols
Get the Yahoo Finance app
- Free real-time data
- News and price alerts
- Add and edit holdings
- Track performance
- Create multiple watchlists
- ABC News Videos•3 days ago
Man falls from ride on Royal Caribbean ship
Casey Holladay, 25, was trying out the cruise ship's new SkyPad ride last month when he suddenly fell about 20 feet.
- FX Empire•yesterday
Forex Daily Recap- European PMI Affecting Major Currencies
Sterling Pound sets off uptrend following Brextension. Lonnie pair uplifts over weak Iran Export numbers. AUD/USD plunges amidst Euro’s Fall.
- FX Empire•yesterday
USD/CAD Daily Price Forecast – US Dollar To Retain Positive Price Action
A sharp decline in crude oil prices undermined Loonie and remained supportive of positive USD price action.
- Zacks•yesterday
Amazon Unveils Belei to Boost Private Label Initiatives
Amazon (AMZN) unveils private-label skincare line called Belei to expand its share in the private label business.
- Market Realist•yesterday
Weak European Data Are Bothering US Investors
Top US Companies Impacted by Slowing European EconomyUS stock marketEarly on March 22, US stock indexes were trading on a negative note. On March 21, the stock indexes ended on a bullish note. On March 21, the S&P 500 Index, the NASDAQ
- FX Empire•2 days ago
Private Sector PMI Numbers Put the EUR into the Spotlight
Economic data comes back into focus today. The Eurozone’s private sector PMI numbers will indicate whether the slowdown was temporary or worsening…
- Zacks•2 days ago
UnitedHealth Group (UNH) Gains But Lags Market: What You Should Know
UnitedHealth Group (UNH) closed at $252.02 in the latest trading session, marking a +0.61% move from the prior day.
- FX Empire•2 days ago
USD/CAD Daily Price Forecast – USD/CAD Trades Upwards As Dovish Fed Update Failed To Have Lasting Impact
CAD gained the upper hand on positive crude oil price. Investors now await macro data updates for directional cues.
- FX Empire•2 days ago
USD/CAD Overview – The Pair Breaking Last Day’s Major Resistance
ADP to release February Canadian Employment Change number today. Trump says US tariffs may sustain for a certain period.
- Zacks•2 days ago
Zacks Market Edge Highlights: Edwards Lifesciences, Exact Sciences, Aimmune Therapeutics, Allergan and Evolus
Zacks Market Edge Highlights: Edwards Lifesciences, Exact Sciences, Aimmune Therapeutics, Allergan and Evolus
Market Realist•2 days agoWhy Analysts Remain on Sidelines for CHD and CLX
What's Ahead for Church & Dwight and Clorox?(Continued from Prior Part)Valuation a concernThe majority of analysts covering Church & Dwight (CHD) and Clorox (CLX) stock maintain a neutral outlook despite better growth prospects among peers.
- FX Empire•3 days ago
The EU Summit and the BoE Put the Pound Back in the Spotlight
The Kiwi and Aussie Dollar find strong support in the wake of a more dovish than expected FED. Will be the BoE sink the Pound later today?
- Zacks•3 days ago
Will Dow Rally Continue in the Long Term? 4 Top Picks
Positive development on the trade war front and the Fed???s dovish monetary stance are likely to be long-term catalysts for the blue-chip index.
- FX Empire•3 days ago
USD Index Licks More Pain After Fed Decision
WTI priced at a 4-month high price. USD/JPY tumbled down to lows. AUD/USD accelerated. Fewer Updates on US-China Trade Talks.
- Zacks•3 days ago
NASH, Allergies and Beauty Stocks: Invest or Not?
There's a lot of innovation going on at the biopharmaceutical companies but which areas should investors be targeting?
- Barrons.com•3 days ago
Allergan Stock Won’t Benefit From a Breakup, Analyst Says
Share are up 15% year to date, helped by the FDA’s acceptance of new applications for Botox. Still, questions remain about the health of the drugmaker’s pipeline and earnings profile.
- FX Empire•3 days ago
USD/CAD Daily Price Forecast – USD/CAD Rangebound Ahead of US FOMC Update
Resurfacing US-China trade tensions and decline in crude oil price helped USD regain upper hand.
- Zacks•3 days ago
WellCare Health Arm MeridianRx Unveils Mobile Application
WellCare Health (WCG) unit introduces a unique mobile app, Atlas Compass, to assist PBM members to manage their pharmacy health information.
- Market Realist•3 days ago
Will Innovation and Higher Pricing Drive Clorox Stock?
What's Ahead for Church & Dwight and Clorox?(Continued from Prior Part)Top line to sustain momentum Clorox (CLX) could continue to report healthy sales growth despite pressure on net sales from currency volatility. Management expects its top
- Zacks•3 days ago
Conatus (CNAT) Focuses on Developing NASH Candidate Emricasan
Conatus (CNAT) concentrates on the development of its lead candidate, emricasan, for treating patients with fibrosis or cirrhosis caused by NASH.
- Zacks•3 days ago
Universal Health's Acute Care Segment Solid, High Debt Ails
Riding high on solid segmental performances, Universal Health (UHS) promises to reap great benefits for investors. However, its debt load bothers.
- Market Realist•3 days ago
Sustained Momentum Could Support CHD
What's Ahead for Church & Dwight and Clorox?(Continued from Prior Part)CHD’s top line could continue to grow Church & Dwight (CHD) has impressed investors with its stellar sales performance in the recent past. The company’s top line has
- Zacks•3 days ago
Service Corp. (SCI) Down 7.1% Since Last Earnings Report: Can It Rebound?
Service Corp. (SCI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Market Realist•3 days ago
What’s Ahead for Church & Dwight and Clorox?
What's Ahead for Church & Dwight and Clorox?Stock performance Church & Dwight (CHD) and Clorox (CLX) have underperformed peers so far this year as margin woes and high valuations are keeping investors on the sidelines. However, we expect
